U.S. Residential REITs Stock News

NasdaqGS:MNDY
NasdaqGS:MNDYSoftware

How Investors May Respond To monday.com (MNDY) AI‑Boosted Earnings Outperformance But Softer Revenue Outlook

monday.com Ltd. has reported past second-quarter 2026 results showing sales of US$364.62 million and net income of US$3.46 million, with both basic and diluted earnings per share from continuing operations at US$0.08, alongside six‑month sales of US$715.89 million and net income of US$31.49 million. While the company delivered record non-GAAP profitability and stronger-than-expected earnings helped by growing AI product adoption, its cautious revenue outlook and signals of moderating growth...
NasdaqGS:ENTG
NasdaqGS:ENTGSemiconductor

Entegris (ENTG) Earnings And Guidance Put Its Valuation Back In Focus

Entegris (ENTG) shares were in focus after the company reported second quarter results with sales of $883.2 million and net income of $93.6 million, along with new guidance for the second half of 2026. See our latest analysis for Entegris. The earnings release and new guidance appear to have shifted sentiment around Entegris, with the share price up 6.61% on the day, delivering a 69.81% year to date share price return and a 111.87% total shareholder return over the past year. This points to...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

Scholar Rock Holding (SRRK) Advances Apitegromab Review, Is 11% Undervalued Enough?

Scholar Rock Holding (SRRK) has drawn fresh attention after reporting second quarter 2026 results, alongside a detailed update on apitegromab’s regulatory path, including progress with the FDA and EMA and preparations for a possible U.S. launch. See our latest analysis for Scholar Rock Holding. The latest apitegromab update appears to have sharpened focus on Scholar Rock Holding, with the stock’s recent 7 day share price return of 15.42% and year to date share price return of 23.64% sitting...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

How Board Loss of Key Clinical Voice Will Impact Aveanna Healthcare Holdings (AVAH) Investors

Aveanna Healthcare Holdings Inc. recently announced that Dr. Erica Schwartz, an independent Class III director and Chair of the Clinical Quality Committee, resigned from its Board on August 5, 2026, following her nomination and confirmation as Director of the U.S. Centers for Disease Control and Prevention. Her departure removes a key clinical oversight voice from Aveanna’s boardroom, while simultaneously linking the company to a high-profile federal public health leadership role. Next,...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Does Elanco (ELAN)ʼs Screwworm EUA Strengthen Its Innovation Story or Expose Pipeline Gaps?

Earlier this month, Elanco Animal Health received U.S. FDA Emergency Use Authorization for its unapproved CLiK Extra wound spray to help prevent New World screwworm infestations across a wide range of livestock and captive wildlife species, alongside existing emergency screwworm products distributed via federal channels. This authorization, arriving just after U.S. authorities confirmed the pest’s reentry, highlights Elanco’s role as a key supplier in addressing an urgent animal health...
NYSE:FTV
NYSE:FTVMachinery

How Fortive’s Q2 Beat and Renewed Buybacks At Fortive (FTV) Has Changed Its Investment Story

In late July 2026, Fortive reported second-quarter revenue of US$1,096.8 million with higher earnings per share from continuing operations year-on-year, while also completing a US$200.07 million share repurchase tranche under its multi-year buyback program. Management reiterated a disciplined capital allocation plan centered on organic investment, accretive bolt-on acquisitions, ongoing buybacks, and a modest growing dividend, supported by a revamped M&A engine now in place. Next, we’ll...
NasdaqGS:MXL
NasdaqGS:MXLSemiconductor

MaxLinear (MXL) Expands AI Storage Ties, Is The Upside Already Priced In?

MaxLinear (MXL) is back on investor radar after a series of AI focused storage and memory announcements, including Core Micro Systems adopting its Panther platform and an MOU with Everspin Technologies on next generation server architectures. See our latest analysis for MaxLinear. These AI focused storage partnerships have arrived alongside sharp share price swings for MaxLinear, with the stock delivering a very large year to date share price return. However, the 30 day and 90 day share price...
NYSE:AHR
NYSE:AHRHealth Care REITs

US REIT Stocks Back In Focus As Lower Yields Lift Healthcare Property Names

Softer US jobs data and easing Treasury yields have quickly shifted attention back to interest rate sensitive areas of the market. That includes US REIT stocks that can feel every move in borrowing costs and inflation expectations. For investors who do not want to wait on the sidelines, this backdrop may create chances to reassess income focused real estate exposure. This article reveals three REIT stocks from the screener that appear positively exposed to the latest macro signals, and...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

Constellation Energy Stock And 2 Nuclear Picks for Reliable Carbon Free Power

Oil price volatility linked to Middle East shipping routes keeps energy security at the center of market conversations. That backdrop puts nuclear energy stocks in sharper focus for investors who want power sources that are not tied to daily oil headlines. The Nuclear Energy Stocks screener filters this broad theme into a focused watchlist. In this article you will see three stand out stocks worth a closer look. The three nuclear energy stocks in this article are just a starting sample, and...
NasdaqGS:CRAI
NasdaqGS:CRAIProfessional Services

CRA International (CRAI) Stock Dropped, So What Is Behind The Latest Attention?

CRA International earnings and capital actions in focus CRA International (CRAI) just released second quarter 2026 results alongside multiple capital decisions, including a refinanced credit facility, a quarterly dividend and continued share repurchases, giving investors several fresh data points to assess. The company reported second quarter sales of US$210.82 million compared with US$186.88 million a year earlier. Net income was US$13.51 million compared with US$12.12 million, with diluted...
NasdaqGM:SHLS
NasdaqGM:SHLSElectrical

Shoals Technologies Group (SHLS) Reaffirms Guidance As TerraFlow Deal Tests Its Valuation

Shoals Technologies Group (SHLS) has just combined a fresh earnings update with reaffirmed 2026 revenue guidance and a new TerraFlow Energy agreement, giving investors new information on growth, margins and future project visibility. See our latest analysis for Shoals Technologies Group. The recent guidance reaffirmation and TerraFlow Energy MOU come after a mixed share price stretch for Shoals Technologies Group, with a 1-day share price return of 3.84% contrasting with a 30-day share price...
NYSE:HCI
NYSE:HCIInsurance

HCI Group (HCI) Stock Climbed, What Is Behind The Fresh Attention?

HCI Group (HCI) stock is in focus after the company released second quarter 2026 results, reporting higher revenue, net income and earnings per share, along with updates on capital returns and business initiatives. See our latest analysis for HCI Group. The earnings release appears to have reinforced recent momentum in HCI Group, with a 1-day share price return of 4.31% and a 90-day share price return of 23.16%. The 3-year total shareholder return above 200% points to strong longer term...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines (ONC) Is Up 11.0% After Raising 2026 Revenue and Operating Income Guidance – What's Changed

BeOne Medicines AG recently reported past second-quarter 2026 results showing revenue of US$1.71 billion and net income of US$237.01 million, with basic earnings per share from continuing operations of US$2.08. For the first half of 2026, revenue reached US$3.22 billion and net income US$464.36 million, and the company also raised full-year 2026 guidance to total revenue of US$6.6 billion–US$6.8 billion and GAAP operating income of US$1.0 billion–US$1.1 billion. Now we will examine how this...
NYSE:LEA
NYSE:LEAAuto Components

Lear (LEA) Raised Full Year Guidance, Is It Still Below Fair Value?

Lear (LEA) drew fresh attention after raising its full-year 2026 revenue guidance to approximately US$23.8b and reporting second-quarter sales of US$6,209.4m with net income of US$192.8m. See our latest analysis for Lear. Lear's recent news around higher full-year revenue guidance and stronger second quarter earnings has come as the share price has been under pressure. The 30 day share price return is down 9.8% and the 90 day share price return is down 9.9%, while the 1 year total shareholder...
NasdaqGS:PNTG
NasdaqGS:PNTGHealthcare

Pennant Group (PNTG) Raised Revenue Guidance, Is The Stock Still Cheap?

Pennant Group (PNTG) has drawn fresh investor attention after reporting second quarter 2026 results with higher sales and net income year on year, along with updated full year revenue guidance in early August. See our latest analysis for Pennant Group. The recent earnings beat and higher full year revenue guidance have come alongside a 40.14% year to date share price return and a 232.20% three year total shareholder return, although short term share price momentum has eased with the stock...
NYSE:NHI
NYSE:NHIHealth Care REITs

Is National Health Investors (NHI) Undervalued After Its New COO Appointment?

Why National Health Investors Stock Is Back on Investors’ Radar National Health Investors (NHI) has drawn fresh attention after appointing senior housing veteran Chris Maingot as Chief Operating Officer on July 27, 2026, ahead of its August 11 earnings call. See our latest analysis for National Health Investors. Against this leadership change backdrop, National Health Investors’ share price has been comparatively steady, with a 90 day share price return of 1.17% and a 1 year total shareholder...
NasdaqGS:TDUP
NasdaqGS:TDUPSpecialty Retail

ThredUp (TDUP) Following New Guidance Still Looks Undervalued On Some Views

Why ThredUp Stock Is Back In Focus After New Guidance ThredUp (TDUP) is drawing fresh attention after releasing second quarter 2026 results, alongside new revenue guidance for the next two quarters and the full year, giving investors updated visibility into the resale platform’s growth profile. See our latest analysis for ThredUp. The updated guidance has arrived after a difficult stretch for ThredUp shareholders, with the stock moving to $3.21 and recording a 7-day share price return down...
NYSE:PUMP
NYSE:PUMPEnergy Services

Oil Stocks To Watch As Strait Of Hormuz Disruption Lifts Energy Prices

Energy stocks are back in the spotlight as shipping traffic through the Strait of Hormuz is disrupted, oil prices react, and headlines move markets day by day. When trade routes shift and risk premiums ripple through the system, certain oil and gas producers can see their prospects change quickly. This article walks through 3 stocks from our Energy Sector Stocks screener that appear positively exposed to the current news story. The three stocks covered below are just a starting sample from...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

ACI Worldwide (ACIW) Is Down 6.4% After Raising 2026 Revenue Guidance And Boosting Buybacks

In August 2026, ACI Worldwide reported higher second-quarter revenue of US$430.42 million and net income of US$31.8 million year-over-year, completed a US$150.61 million share repurchase tranche, raised its full-year 2026 revenue guidance to US$1.895–1.925 billion, and reiterated plans to pursue cloud-focused acquisitions. An underappreciated angle is how ACI’s mix of buybacks, potential M&A, and its new dLocal payments partnership in Latin America underscores a capital allocation approach...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

What Incyte (INCY)'s Expanded Opzelura EU Approval Means For Shareholders

In the past week, Incyte reported that the European Commission approved Opzelura (ruxolitinib) cream for moderate atopic dermatitis in adults who do not respond adequately to or cannot use standard topical therapies, expanding the drug’s European label beyond non-segmental vitiligo. This decision, backed by strong Phase 3 data showing rapid itch relief and durable skin clearance with a favorable safety profile, coincided with Incyte posting higher quarterly revenue and net income and raising...
NasdaqGS:EVCM
NasdaqGS:EVCMSoftware

Why EverCommerce (EVCM) Is Down 8.8% After Softened 2026 Outlook And CEO Transition - And What's Next

EverCommerce Inc. has reported past second-quarter 2026 results showing revenue of US$152.02 million and net income of US$9.72 million, while also tightening its full-year 2026 revenue outlook toward the lower end of its US$612 million to US$632 million guidance range. On top of these earnings and guidance updates, the board’s decision to appoint experienced technology operator Alex Goor as CEO and director, with founder Eric Remer stepping back from executive leadership but remaining on the...
NasdaqGS:CHEF
NasdaqGS:CHEFConsumer Retailing

Did Chefs' Warehouse's (CHEF) Strong Q2 and New Term Loan Just Redefine Its Investment Narrative?

In late July 2026, The Chefs' Warehouse, Inc. reported higher second-quarter sales of US$1,168.61 million and net income of US$33.77 million year over year, then in early August began marketing a new US$625 million term loan facility to refinance existing debt and convertible notes, cover related costs, and support general corporate purposes. Taken together, stronger recent profitability, raised full-year 2026 sales guidance of US$4.50 billion to US$4.60 billion, and a potential balance...
NYSE:MMS
NYSE:MMSProfessional Services

Did Lowered 2026 Guidance After VA Incentive Pause Just Shift Maximus' (MMS) Investment Narrative?

In August 2026, Maximus, Inc. reported third-quarter results showing revenue of US$1,278.97 million and net income of US$103.59 million, while also updating its fiscal 2026 guidance to revenue of US$5.20–US$5.35 billion, net income of US$376–US$392 million, and diluted EPS of US$6.94–US$7.24, with outcomes expected toward the lower end of ranges. The company’s revised outlook followed a Department of Veterans Affairs decision to pause performance incentives on its Medical Disability Exam...
NYSE:SITE
NYSE:SITETrade Distributors

SiteOne’s Buybacks And Acquisition Push Could Be A Game Changer For SiteOne Landscape Supply (SITE)

In late July 2026, SiteOne Landscape Supply reported second-quarter sales of US$1,530.7 million and net income of US$139.3 million, alongside confirmation that it had repurchased 897,778 shares for US$103.76 million under its ongoing buyback program. Management also highlighted an active acquisition pipeline, with two deals already completed in 2026 adding about US$110 million in trailing sales, signalling continued emphasis on growth through consolidation in a fragmented landscape supply...